Press Release

TGaS Advisors Named to 2008 Inc. 500, Shows Third Fastest Growth in Mid-Atlantic Region

East Norriton, Penn., August 20, 2008 — TGaS Advisors, the leader in benchmark and advisory services for pharmaceutical commercial operations, was today named to Inc. magazine’s 27th annual Inc. 500 list of the fastest-growing private companies in the United States, published in the magazine’s September issue. TGaS Advisors is the third fastest growing company in the Mid-Atlantic region (PA-NJ-DE-MD) on the list, with a three-year growth rate of 1,380.3 percent, and it placed ninth on the list of health companies. Ranked at the #173 position, TGaS Advisors achieved its exponential growth organically with no outside investment.

Managing Partner Stephen E. Gerard attributes TGaS Advisors’ growth to the firm’s collaborative relationship with clients and success in meeting their needs. According to Gerard, the firm’s achievements arise from TGaS Advisors’ unique concept of working from the “outside-in,” creating a community of operations executives and providing confidential fact-based answers to the question, “How do other pharmaceutical companies do ‘it’?”^® In 2007 alone, revenues grew by more than 50 percent, the number of employees more than doubled, and the client roster grew by 75 percent. Most employees are 20-year industry veterans, coming to TGaS Advisors from such companies as Wyeth, Roche Pharmaceuticals, Schering-Plough, King Pharmaceuticals, Abbott Laboratories, Yamanouchi (Astellas), IMS Health and SimStar.

“TGaS Advisors is on the cutting edge of collaborative benchmarking in the pharmaceutical industry because we give senior operations executives what no one else provides – a way to measure where they stand in relation to their peers and exert leadership within their own companies,” said Gerard. “We create collaborative peer-sets, giving operations executives the opportunity to leverage the firm’s deep database, expansive network and the experience of TGaS Advisors associates.”

Clients receive fact-based insights comparing their sales, marketing and managed market support operations to a confidential, blinded peer-set. TGaS Advisors does not syndicate its data or sell ancillary follow-on services, ensuring that information is objective. Senior advisors communicate findings exclusively to peer-set participants, providing insights specific to each client and addressing strategy, tactics and optimal practices based on results and industry experience. Presentations also show the broader impact on operational ”ecosystems.”

Inc. editor Jane Berentson ascribed a larger significance to the achievements of TGaS Advisors and its peers on the prestigious list. “If you want to find out which companies are going to change the world, look at the Inc. 500,” she said. “These are the most innovative, dynamic, fast-growing companies in the nation – the ones coming up with solutions to some of our knottiest problems, creating systems that let us conduct business faster and easier, and manufacturing products we soon discover we can’t live without. The Inc. 500 list is Inc. magazine’s tribute to American business ingenuity and ambition.”

The 2008 Inc. 500/5000 list measures revenue growth from 2004 through 2007. To qualify, companies must be U.S.-based and privately held, independent – not subsidiaries or divisions of other companies – as of December 31, 2007, and have had at least $200,000 in revenue in 2004 and $2 million in 2007. Complete information on this year’s Inc. 500, including company profiles and a list of the fastest-growing companies that can be sorted by industry and region, can be found at www.inc5000.com.

About TGaS^® Advisors LLC

TGaS Advisors is the leader in benchmarking and advisory services to the pharmaceutical and biopharmaceutical industry. The TGaS Advisors roster includes the majority of the top 50 pharmaceutical companies with operations in the U.S. market. The firm’s benchmarking and advisory suite of solutions, PharmaStance^®, provides clients with a way to measure where they stand with respect to their operations and answers the question, “How do other pharmaceutical companies do ‘it’?” TGaS Advisors is based in East Norriton, Pennsylvania. To learn more, visit www.tgas.com.

About Inc. magazine

Founded in 1979 and acquired in 2005 by Mansueto Ventures, LLC., Inc. magazine (www.inc.com) is the only major business magazine dedicated exclusively to owners and managers of growing private companies that delivers real solutions for today’s innovative company builders. With a total paid circulation of 724,110, Inc. provides hands-on tools and market tested strategies for managing people, finances, sales, marketing and technology.

Other Press Releases:

Record Number of Pharma Operations Leaders Share Challenges, Solutions at Four TGaS Advisors Forums

“Turning Prophets into Strategists and Leaders” Seen as Opportunity for Market Research; Theme of Pharma Market Research Group Presentation

TGaS Advisors Named to Philadelphia 100^®, Ranked 18th Among Region’s Fastest Growing Privately Held Companies

Sharon Patent Appointed Director, Marketing Sciences Operations Practices, at TGaS Advisors, Adding New Dimension to Analytics Capabilities

Top Pharma Execs Discuss Regionalization and Outsourcing Trends at TGaS^® Advisors Operations Forum

TGaS Advisors Launches Internet Performance Benchmark

TGaS Advisors’ Gerard Moderates Featured Panel at CBI Pharma Leadership Summit on Impact of Innovation on Sales Operations

TGaS Advisors’ Castello Offers Advice on Managing Changes in Pharma Sales Compensation Plans

TGaS Advisors Leader Steve Gerard Named One of “100 Most Inspiring People” by PharmaVoice Magazine

TGaS Advisors Launches Organization and Career Guide Benchmark for Pharma Sales Operations

TGaS Advisors Appoints James P. Castello Director, Management Advisor

TGaS Advisors Named as Finalists In 2008 American Business Awards

TGaS Advisors Hires Brian Bamberger to Spearhead Managed Markets Benchmarks

Pharma Marketing Sciences Execs Learn “How Other Companies Do It” at TGaS Advisors Client Forum

TGaS Advisors’ Wojcik Analyzes Incentive Compensation Issues at Pharma Sales Force Performance Conference

TGaS Advisors Expands Executive Ranks to Accommodate Business Growth; Pharma Veteran John P. Carro Joins as Vice President, Management Advisor

TGaS Advisors TGaS Advisors Creates New Position to Accommodate Business Growth; Pharma Veteran Tom Bang Joins as Executive in Residence

TGaS Advisors Creates New Position; Pharma Veteran Gary McWalters Joins as Director of Marketing and Business Development

TGaS Advisors Expands Staff to Accommodate Business Growth Robert Shewbrooks Joins Firm as Vice President, Management Advisor

TGaS Advisors Appoints Boucher to New Analytics, Outreach Position

TGaS Advisors Moves into New Corporate Headquarters

TGaS Advisors Launches Compliance Operations Benchmark (COPs)

TGaS Advisors Hires Jeff Wojcik and Donna Wray

TGaS Advisors Offers Collaborative Benchmarking Services for Pharmaceutical Companies